BLOG
CONTACT
ACCOUNT
Account
中文
0 Items
About
Our Mission
Compliance
Leadership
Advisors
Investor
Distributors
Partners
Awards
Careers
Contact
Technology
XNA Molecular Clamp
SuperbDNA™ Next Generation bDNA Signal Amplification Technology
Products
COVID-19 Total Solution
QuantiVirus™ SARS-CoV-2 Test (FDA EUA)
QuantiVirus™ SARS-CoV-2 Multiplex Test (FDA EUA)
QuantiVirus™ SARS-CoV-2 Variants Detection Test
QuantiVirus™ Anti-SARS-CoV-2 IgG Test
QuantiVirus™ SARS-CoV-2 Antigen Test
COVID-19 Clinical Laboratory Testing Service
QClamp® Gene Mutation Detection Tests
KRAS Mutation Detection Test
NRAS Mutation Detection Test
EGFR Mutation Detection Test
BRAF Mutation Detection Test
JAK2 Mutation Detection Test
PIK3CA Mutation Detection Test
BRAF V600 Mutation-Enriching Sanger Sequencing
ColoScape™ Colorectal Cancer Mutation Detection Test
QuantiVirus™ HPV E6/E7 mRNA Test
Direct Human DNA Quantification
By Platform
Luminometer-Based Platform – VznHealth™
Luminex-Based Platform – QuantiDNA™
By Application
Generic cfDNA Quantification
Radiotherapy Toxicity Measurement Assay
Residual Host Cell DNA Quantitation
CRISPR-Quest Gene Editing Test
Dimerator™ Adapter Dimer Removal
VznHealth™ Benchtop Luminometer
Thermo Shaker Incubator
QFusion™ EML4-ALK and KIF5B-ALK Fusion Gene Detection Kit
Services
RadTox™ Radiation Safety Test Service
ColoScape™ Colorectal Cancer Mutation Detection Test Service
OptiSeq™ NGS Targeted Sequencing
OptiSeq™ Pan-Cancer Panel (65 Gene)
Next-Gen Sequencing
Companion Diagnostics
Personalized CAR-T Immunotherapy Platform
Resources
Blog
Conferences
Press Releases
Resources
Publications
COVID-19 Testing Service
COVID-19 Drive-Through PCR Testing Service
Select Page
Events
Current Month
may, 2022
No Events
Search for:
Recent Posts
DiaCarta Expands Board Leadership with Industry Veteran
DiaCarta Enters a Cooperative Research and Development Agreement (CRADA) with the National Cancer Institute (NCI) to Develop Cancer Tests based on its Novel XNA Technology
Diagnostic Developers Pursue SARS-CoV-2 Omicron Assays for Surveillance, Potential Clinical Use
DiaCarta’s Multivariant COVID-19 Test Accurately Detects the Omicron Variant
Early Cancer Detection Will Save More Lives
Recent Comments
Archives
April 2022
January 2022
December 2021
November 2021
October 2021
September 2021
August 2021
May 2021
April 2021
November 2020
October 2020
September 2020
July 2020
April 2020
March 2020
August 2019
April 2019
January 2019
November 2018
October 2018
September 2018
August 2018
July 2018
June 2018
May 2018
April 2018
February 2018
October 2017
July 2017
February 2017
October 2016
September 2016
April 2016
March 2016
April 2015
January 2015
February 2014
October 2013
Categories
Blog
GenomeWeb
Press Releases
Publications
Meta
Log in
Entries feed
Comments feed
WordPress.org
About
Our Mission
Compliance
Leadership
Advisors
Investor
Distributors
Partners
Awards
Careers
Contact
Technology
XNA Molecular Clamp
SuperbDNA™ Next Generation bDNA Signal Amplification Technology
Products
COVID-19 Total Solution
QuantiVirus™ SARS-CoV-2 Test (FDA EUA)
QuantiVirus™ SARS-CoV-2 Multiplex Test (FDA EUA)
QuantiVirus™ SARS-CoV-2 Variants Detection Test
QuantiVirus™ Anti-SARS-CoV-2 IgG Test
QuantiVirus™ SARS-CoV-2 Antigen Test
COVID-19 Clinical Laboratory Testing Service
QClamp® Gene Mutation Detection Tests
KRAS Mutation Detection Test
NRAS Mutation Detection Test
EGFR Mutation Detection Test
BRAF Mutation Detection Test
JAK2 Mutation Detection Test
PIK3CA Mutation Detection Test
BRAF V600 Mutation-Enriching Sanger Sequencing
ColoScape™ Colorectal Cancer Mutation Detection Test
QuantiVirus™ HPV E6/E7 mRNA Test
Direct Human DNA Quantification
By Platform
Luminometer-Based Platform – VznHealth™
Luminex-Based Platform – QuantiDNA™
By Application
Generic cfDNA Quantification
Radiotherapy Toxicity Measurement Assay
Residual Host Cell DNA Quantitation
CRISPR-Quest Gene Editing Test
Dimerator™ Adapter Dimer Removal
VznHealth™ Benchtop Luminometer
Thermo Shaker Incubator
QFusion™ EML4-ALK and KIF5B-ALK Fusion Gene Detection Kit
Services
RadTox™ Radiation Safety Test Service
ColoScape™ Colorectal Cancer Mutation Detection Test Service
OptiSeq™ NGS Targeted Sequencing
OptiSeq™ Pan-Cancer Panel (65 Gene)
Next-Gen Sequencing
Companion Diagnostics
Personalized CAR-T Immunotherapy Platform
Resources
Blog
Conferences
Press Releases
Resources
Publications
COVID-19 Testing Service
COVID-19 Drive-Through PCR Testing Service
BLOG
CONTACT
ACCOUNT
Account
中文
Register and Learn!
Join our mailing list to receive the latest news and updates from our team.
You have Successfully Subscribed!
X
Recent Comments